BeStock  
Stocks › Biotechnology › ORKA

Oruka Therapeutics ORKA

US equityMarket cap rank #1788Biotechnology
$95.81 −$1.76 (-1.80%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $95.81 0.00%
Open$95.86
Prev close$97.57
Day range$93.30 – $97.24
Volume1.98M
Market cap$6.50B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-49.7x
CheapRich

Near the bottom of its 5-year range · 17th percentile, 5-year average -21.5x

Price / book6.0x
CheapRich

Near the top of its 5-year range · 92nd percentile, 5-year average 1.7x

#4561 of 5331 stocks by PB (1 = cheapest)

P/E over five years

-101x-63x-24x14xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$100.30
Price vs. fair value-4.5%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 5.98 – 1.71 92% (pricier than usual) #4561 of 5331 (1 = cheapest)
PE -49.69 -31.18 -21.51 17% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ORKA.

Sign in to join the discussion.

Scroll to Top